Discovering how to identify new psychoactive substances through PhD research Researcher Amira Guirguis is designing a model to improve on-site identification of new psychoactive substances of misuse. She explains why the work is vital to reduce unnecessary hospital admissions and prevent avoidable deaths.…
The Pharmaceutical Journal’s top 5 comment pieces of 2014Benedict Lam takes a look back on the most popular and talked about comment pieces of 2014…
Antipsychotics are being used for anxiety and dementia, despite licensed indicationsA large proportion of people prescribed antipsychotics do not have a diagnosis of psychosis or bipolar disorder, research indicates.…
Merton Sandler (1926-2014) Merton Sandler was fascinated by investigative medicine and was a passionate researcher, who would often use himself as a test subject.…
Psychedelics: entering a new age of addiction therapy Psilocybin, the compound that makes mushrooms magic, is showing promise as a treatment for several psychiatric illnesses.…
Fluoxetine is the only antidepressant to be used in bipolar disorder, NICE says NICE is now focusing on the effectiveness of individual drugs, rather than the tradition of recommending drug classes as a whole for its bipolar guidance.…
Take action to prevent misuse of psychotropic medicines in care homes English Pharmacy Board chairman Dave Branford makes the case for pharmacists to have more input into care home prescribing.…
